DK0829011T3 - Inhibition af frisætning af amylin - Google Patents

Inhibition af frisætning af amylin

Info

Publication number: DK0829011T3
Authority: DK; Denmark
Prior art keywords: compound; sstr; amylin; release; ligand
Prior art date: 1995-05-12

Application number

DK96914208T

Other languages

English (en)

Inventor

Simon Jon Dunmore

Michelle Davenport

Michael Anthony Cawthorne

Original Assignee

Univ Buckingham

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-12

Filing date

1996-05-11

Publication date

2002-10-28

1996-05-11 Application filed by Univ Buckingham filed Critical Univ Buckingham

2002-10-28 Application granted granted Critical

2002-10-28 Publication of DK0829011T3 publication Critical patent/DK0829011T3/da

Links

102000036770 Islet Amyloid Polypeptide Human genes 0.000 title abstract 6
108010041872 Islet Amyloid Polypeptide Proteins 0.000 title abstract 6
230000005764 inhibitory process Effects 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 7
239000003446 ligand Substances 0.000 abstract 4
238000000034 method Methods 0.000 abstract 3
102000005157 Somatostatin Human genes 0.000 abstract 1
108010056088 Somatostatin Proteins 0.000 abstract 1
230000035877 hyperamylinemia Effects 0.000 abstract 1
239000012528 membrane Substances 0.000 abstract 1
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 abstract 1
229960000553 somatostatin Drugs 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/655—Somatostatins
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Endocrinology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Biochemistry (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
General Chemical & Material Sciences (AREA)
Microbiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Steroid Compounds (AREA)
Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
Medicines Containing Plant Substances (AREA)

DK96914208T 1995-05-12 1996-05-11 Inhibition af frisætning af amylin DK0829011T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/440,061 US5763200A (en)	1995-05-12	1995-05-12	Inhibition of amylin release
PCT/EP1996/002064 WO1996035950A1 (en)	1995-05-12	1996-05-11	Inhibition of amylin release

Publications (1)

Publication Number	Publication Date
DK0829011T3 true DK0829011T3 (da)	2002-10-28

Family

ID=23747259

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96914208T DK0829011T3 (da)	1995-05-12	1996-05-11	Inhibition af frisætning af amylin

Country Status (13)

Country	Link
US (3)	US5763200A (da)
EP (1)	EP0829011B1 (da)
JP (1)	JPH11505611A (da)
AT (1)	ATE223045T1 (da)
AU (1)	AU694360B2 (da)
CA (1)	CA2220106A1 (da)
DE (1)	DE69623280T2 (da)
DK (1)	DK0829011T3 (da)
ES (1)	ES2180769T3 (da)
MX (1)	MX9708740A (da)
NZ (1)	NZ308105A (da)
PT (1)	PT829011E (da)
WO (1)	WO1996035950A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6004928A (en) *	1997-05-13	1999-12-21	Biomeasure, Incorporated	Method of treating hyperlipidemia
US7026289B2 (en)	1997-05-13	2006-04-11	Societe De Conseils De Recherches Et D'applications Scientifiques, Sas	Method and compositions for treating hyperlipidemia and other conditions
AU7655098A (en) *	1997-05-13	1998-12-08	Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.)	Somatostatin and somatostatin agonists for decreasing body weight
ES2216290T3 (es) *	1997-05-13	2004-10-16	Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S.	Somatostatina y agonistas de la somatostatina para el tratamiento de insensibilidad a la insulina y de sindrome x.
US6440933B1 (en) *	1997-09-10	2002-08-27	University Of Florida	Compounds and method for the prevention and treatment of diabetic retinopathy
CA2325169A1 (en)	1999-12-03	2001-06-03	Ndsu Research Foundation	Somatostatins and method
EP1369698A1 (en) *	2002-06-07	2003-12-10	Bayer Ag	Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (SSTR5)
WO2005027981A1 (en) *	2003-09-17	2005-03-31	Board Of Regents, The University Of Texas System	Mechanism-based targeted pancreatic beta cell imaging and therapy
JP4365743B2 (ja) *	2004-07-27	2009-11-18	富士通マイクロエレクトロニクス株式会社	撮像装置
EP3746459A1 (en) *	2018-02-02	2020-12-09	Univerza V Ljubljani	Affinity ligands for antibody fc region

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5260275A (en) *	1990-08-14	1993-11-09	Amylin Pharmaceuticals, Inc.	Hypoglycemics
US5234906A (en) *	1991-01-10	1993-08-10	Amylin Pharmaceuticals, Inc.	Hyperglycemic compositions
US5436155A (en) *	1991-12-31	1995-07-25	Arch Development Corporation	Isolated DNA encoding a somatostatin receptor

1995
- 1995-05-12 US US08/440,061 patent/US5763200A/en not_active Expired - Fee Related
1996
- 1996-05-11 JP JP8533796A patent/JPH11505611A/ja active Pending
- 1996-05-11 AT AT96914208T patent/ATE223045T1/de not_active IP Right Cessation
- 1996-05-11 ES ES96914208T patent/ES2180769T3/es not_active Expired - Lifetime
- 1996-05-11 DK DK96914208T patent/DK0829011T3/da active
- 1996-05-11 PT PT96914208T patent/PT829011E/pt unknown
- 1996-05-11 WO PCT/EP1996/002064 patent/WO1996035950A1/en not_active Ceased
- 1996-05-11 DE DE69623280T patent/DE69623280T2/de not_active Expired - Fee Related
- 1996-05-11 EP EP96914208A patent/EP0829011B1/en not_active Expired - Lifetime
- 1996-05-11 MX MX9708740A patent/MX9708740A/es unknown
- 1996-05-11 NZ NZ308105A patent/NZ308105A/en unknown
- 1996-05-11 AU AU57645/96A patent/AU694360B2/en not_active Ceased
- 1996-05-11 CA CA002220106A patent/CA2220106A1/en not_active Abandoned
1997
- 1997-10-31 US US08/961,968 patent/US6774109B2/en not_active Expired - Fee Related
2004
- 2004-01-08 US US10/753,717 patent/US20040146951A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP0829011A1 (en)	1998-03-18
ES2180769T3 (es)	2003-02-16
PT829011E (pt)	2003-01-31
US20010006790A1 (en)	2001-07-05
DE69623280D1 (de)	2002-10-02
ATE223045T1 (de)	2002-09-15
NZ308105A (en)	1999-04-29
MX9708740A (es)	1997-12-31
US20040146951A1 (en)	2004-07-29
CA2220106A1 (en)	1996-11-14
WO1996035950A1 (en)	1996-11-14
EP0829011B1 (en)	2002-08-28
US5763200A (en)	1998-06-09
US6774109B2 (en)	2004-08-10
AU694360B2 (en)	1998-07-16
DE69623280T2 (de)	2003-05-22
JPH11505611A (ja)	1999-05-21
AU5764596A (en)	1996-11-29

Publication	Publication Date	Title
DK0708922T3 (da)	1999-09-27	Identificering af ligander ved selektiv amplifikation af celler transfekteret med receptorer
NO970891L (no)	1997-02-27	Aerogelholdige komposittmaterialer, fremgangsmåte for fremstilling av disse samt deres anvendelse
DE69901714D1 (de)	2002-07-11	Elektrochemischer affinitätsassay
DK0829011T3 (da)	2002-10-28	Inhibition af frisætning af amylin
EP0803577A3 (en)	1998-12-02	Method for detecting and/or determining ATP from microorganism cells in a sample
TR200101834T2 (tr)	2001-12-21	Yeni tiroid reseptör ligandları ve yöntem II
WO2000005265A3 (en)	2000-04-27	Anti-crr2 antibodies and methods of use therefor
EP0734264A4 (en)	1999-04-21	CONNECTIONS SPECIFICALLY BINDING TO COLORECTAL CANCER CELLS AND METHOD FOR THEIR PRODUCTION
EP1985632A3 (en)	2008-11-12	Use of VEGF2 antibodies for inhibiting photoreceptor cell proliferation
EP0496832A4 (en)	1993-02-17	Inhibition of padgem-mediated cell binding
DK0809807T3 (da)	2002-11-25	Immunoassay til tælling af celler
AU4626085A (en)	1986-03-06	Electrochemical cell for detecting noxious gases
NZ230389A (en)	1991-11-26	In-situ hybridisation assay of intact membrane specimens capable of detecting small amounts of biopolymers per cell
ATE170092T1 (de)	1998-09-15	Künstliche rezeptoren, antikörper und enzyme
WO2001007088A3 (en)	2001-11-15	Methods for treating therapy-resistant tumors
WO2000000599A3 (en)	2000-03-23	Composition for the induction of apoptosis in target cells
WO2003019136A3 (en)	2003-11-20	Methods for inhibiting angiogenesis
GB2342652A (en)	2000-04-19	Polypeptides comprising a coiled-coil and an addition
WO2001048466A3 (de)	2002-02-21	Sensorelement eines gassensors zur bestimmung von gaskomponenten
WO2000004152A3 (en)	2000-04-27	Androgen receptor coactivators
CA2213083A1 (en)	1996-08-29	Detection of antibody production
WO2000077241A3 (en)	2001-03-22	Heparanase assay
DK0549776T4 (da)	2002-07-29	System af prober, som gør det muligt at gennemføre HLA DR-typebestemmelse, og fremgangsmåde til typebestemmelse ved anvendelse af disse prober
IL137865A0 (en)	2001-10-31	Method for the diagnosis and follow-up of schizophrenia
AU2434400A (en)	2000-07-24	Method for the cellular high-throughput-detection of nuclear receptor ligand interactions